Alessia Ciancio

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 13

Top Topics

Ejection Fraction

Prognostic Factors

Hepatitis C Virus

Top Venues

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Alessia Ciancio, Davide Giuseppe Ribaldone, Matteo Spertino, Alessandra Risso, Debora Ferrarotti, Gian Paolo Caviglia, Patrizia Carucci, Silvia Gaia, Emanuela Rolle, Marco Sacco, Giorgio Maria Saracco
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study. Biomedicines 11 (1) (2023)
Gian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, Patrizia Carucci, Emanuela Rolle, Alessandra Risso, Michela Emma Burlone, Alice Albè, Martina Crevola, Emma Clara Musso, Chiara Rosso, Angelo Armandi, Antonella Olivero, Rosalba Minisini, Giorgio Maria Saracco, Elisabetta Bugianesi, Mario Pirisi, Alessia Ciancio, Silvia Gaia
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development. Biology 12 (1) (2023)
Alessia Ciancio, Davide Giuseppe Ribaldone, Matteo Spertino, Alessandra Risso, Debora Ferrarotti, Gian Paolo Caviglia, Patrizia Carucci, Silvia Gaia, Emanuela Rolle, Marco Sacco, Giorgio Maria Saracco
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study. Biomedicines 11 (1) (2023)
Gian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, Patrizia Carucci, Emanuela Rolle, Alessandra Risso, Michela Emma Burlone, Alice Albè, Martina Crevola, Emma Clara Musso, Chiara Rosso, Angelo Armandi, Antonella Olivero, Rosalba Minisini, Giorgio Maria Saracco, Elisabetta Bugianesi, Mario Pirisi, Alessia Ciancio, Silvia Gaia
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development. Biology 12 (1) (2023)
Alessia Ciancio, Davide Giuseppe Ribaldone, Matteo Spertino, Alessandra Risso, Debora Ferrarotti, Gian Paolo Caviglia, Patrizia Carucci, Silvia Gaia, Emanuela Rolle, Marco Sacco, Giorgio Maria Saracco
Who Should Not Be Surveilled for HCC Development after Successful Therapy with DAAS in Advanced Chronic Hepatitis C? Results of a Long-Term Prospective Study. Biomedicines 11 (1) (2023)
Gian Paolo Caviglia, Maria Lorena Abate, Giulia Troshina, Patrizia Carucci, Emanuela Rolle, Alessandra Risso, Michela Emma Burlone, Alice Albè, Martina Crevola, Emma Clara Musso, Chiara Rosso, Angelo Armandi, Antonella Olivero, Rosalba Minisini, Giorgio Maria Saracco, Elisabetta Bugianesi, Mario Pirisi, Alessia Ciancio, Silvia Gaia
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development. Biology 12 (1) (2023)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Loreta Anesti Kondili, Monica Monti, Maria Giovanna Quaranta, Laura Gragnani, Valentina Panetta, Giuseppina Brancaccio, Cesare Mazzaro, Marcello Persico, Mario Masarone, Gentile Ivan, Pietro Andreone, Salvatore Madonia, Elisa Biliotti, Roberto Filomia, Massimo Puoti, Anna Ludovica Fracanzani, Diletta Laccabue, Donatella Ieluzzi, Carmine Coppola, Maria Grazia Rumi, Antonio Benedetti, Gabriella Verucchi, Barbara Coco, Liliana Lc Chemello, Andrea Iannone, Alessia Ciancio, Francesco Paolo Russo, Francesco Barbaro, Filomena Morisco, Luchino Chessa, Marco Massari, Pierluigi Blanc, Anna Linda Zignego
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort. Hepatology (Baltimore, Md.) 76 (1) (2022)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Claudio Borghi, Alessia Ciancio, Gentile Ivan, Pasquale Perrone Filardi, Patrizio Pasqualetti, Stefano Brillanti
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project. Journal of clinical medicine 11 (23) (2022)
Gian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
A Review of HDV Infection. Viruses 14 (8) (2022)
Chiara Rosso, Cristina Demelas, Greta Agostini, Maria Lorena Abate, Marta Vernero, Gian Paolo Caviglia, Daphne D'Amato, Angelo Armandi, Marta Tapparo, Marta Guariglia, Giulia Troshina, Alessandro Massano, Antonella Olivero, Aurora Nicolosi, Antonella Zannetti, Rinaldo Pellicano, Alessia Ciancio, Giorgio Maria Saracco, Davide Giuseppe Ribaldone, Elisabetta Bugianesi, Sharmila Fagoonee
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis. Viruses 14 (11) (2022)